Where To Inject Semaglutide: Technique, Rotation Sites, Provider Guidance

Last reviewed: May 28, 2026

Last updated: May 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Semaglutide is administered as a subcutaneous injection into the abdomen, thigh, or upper arm, with careful site rotation essential for optimal absorption and tissue health. Rotating injection sites every week helps prevent lipohypertrophy—localized thickening of fatty tissue—which can impair medication absorption and consistency.

Understanding proper injection technique, anatomical landmarks, and rotation protocols supports treatment tolerability and clinical outcomes. PlexusDx prioritizes precision-wellness approaches that consider individual factors—including genetic predispositions in peptide pathways—to help you and your provider optimize both injection practice and medication selection.

Anatomically Safe Injection Sites for Subcutaneous Administration

The FDA-approved injection sites for semaglutide include the anterior abdomen (at least 2 inches from the navel), lateral thigh, or back of the upper arm. Each site offers adequate subcutaneous tissue depth and reduced risk of intramuscular or intravascular injection when proper technique is used.

The abdomen typically absorbs semaglutide fastest, while thigh and upper arm absorption may be slightly slower. Your healthcare provider should assess your individual anatomy to identify optimal sites based on available subcutaneous tissue, skin integrity, and personal comfort.

Site Rotation Framework and Injection Spacing

Systematic rotation prevents lipohypertrophy and ensures consistent medication absorption. A rotating schedule spaces injections at least 1 inch apart within the same anatomical region and alternates between regions weekly. This practice maintains tissue integrity and supports predictable pharmacokinetics.

Injection Site Region	Recommended Spacing	Rotation Schedule	Key Consideration
Abdomen	At least 2 inches from navel; minimum 1 inch between injections	Rotate to new site each week within region	Fastest absorption; largest usable area
Lateral Thigh	Outer front or side; minimum 1 inch between injections	Alternate left and right; rotate weekly	Moderate absorption; stable tissue depth
Upper Arm	Back or outer surface; minimum 1 inch between injections	Rotate between left and right; less frequent	Slightly slower absorption; limited area
All Regions	Avoid bruised, hardened, or thickened areas	Use site map or digital tracker for consistency	Prevents lipohypertrophy and injection pain

Injection Technique and Needle Insertion Angle

Semaglutide pens typically use 4–6 mm needles inserted at 90 degrees to the skin surface, creating a perpendicular angle that reaches subcutaneous tissue without penetrating deeper layers. Pinching a small fold of skin before insertion can increase tissue accessibility and reduce discomfort.

Research indicates that consistent insertion angle and controlled injection speed (3–5 seconds for full dose delivery) minimize tissue trauma and pain responses. Your provider or pharmacist should demonstrate proper hand positioning and pen grip during your initial patient training.

Preventing Lipohypertrophy and Monitoring Injection Site Health

Lipohypertrophy—abnormal fatty tissue thickening—can reduce medication absorption by up to 30% and increase injection variability. This occurs when injections cluster in the same small area, triggering chronic tissue irritation. Regular visual and tactile inspection (feeling for lumps or hardness) is essential.

If you notice firmness, redness, or thickening at injection sites, notify your healthcare provider immediately. Temporary site rest (switching regions for 2–4 weeks) typically allows tissue recovery. Your provider should assess whether absorption issues are affecting your clinical response and adjust dosing strategy if needed.

How PlexusDx Supports a More Personalized Approach

Individual genetic variation in GLP-1 receptor expression and peptide signaling pathways may influence how consistently you respond to semaglutide. PlexusDx Precision Peptide Genetic Test examines key variants (GLP1R rs6923761, GIPR rs1800437, and related markers) that can help provide context for your baseline medication sensitivity and may inform whether consistent, precise injection technique is especially important for your clinical profile.

The test does not predict exact medication response but reveals predispositions in peptide genetic pathways that your provider can interpret alongside your clinical presentation. Understanding whether you carry genetic variants associated with differential GLP-1 receptor sensitivity should be discussed with your healthcare provider as part of your comprehensive treatment plan.

Combining proper injection technique—including rigorous site rotation and lipohypertrophy prevention—with personalized biomarker insights can support a more informed conversation with your provider about expected medication efficacy, dose requirements, and whether additional monitoring or protocol adjustments may benefit your treatment outcome.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide into the same spot every week?

No. Repeated injections in the same location cause lipohypertrophy, reducing medication absorption by 20–30%. Rotate to a new site at least 1 inch away each week. Your provider should confirm your rotation pattern at follow-up visits.

What angle should the needle enter the skin?

Insert the needle at 90 degrees perpendicular to the skin surface. Most semaglutide pens use 4–6 mm needles designed for subcutaneous (not intramuscular) delivery. Your pharmacist or provider should demonstrate proper technique during initial training.

Does PlexusDx offer compounded semaglutide with injection guidance?

Yes. PlexusDx offers compounded semaglutide injection ($149/mo) from licensed 503A pharmacies. Your provider will supply injection training; our team can answer questions about dosing and administration at follow-up appointments.

What should I do if I develop a lump at an injection site?

Stop injecting in that region for 2–4 weeks to allow tissue recovery. Contact your provider to evaluate the lump and confirm it is lipohypertrophy (not infection or hematoma). Adjust your rotation plan to prevent recurrence.

How does the Precision Peptide Genetic Test relate to injection technique?

The test reveals genetic predispositions in GLP-1 receptor pathways that may inform baseline medication sensitivity. Genetic insights combined with flawless injection technique help ensure your semaglutide reaches target tissue concentration consistently and effectively.